Virginie Penard‐Lacronique
0000-0001-9435-7331
Publication & Citation Trends
Publications
77 total
Abstract 280: Aberrant β-catenin signaling from the bone marrow niche leads to transformation of IDH1/2-mutant hematopoietic stem cells and compromises response to IDH1/2 inhibitors
Cited by 0
Semantic Scholar
Dysregulation of chromatin via H3K27 methylation underpins differentiation arrest in Isocitrate dehydrogenase-mutant Acute Myeloid Leukaemia OA
Cited by 1
Semantic Scholar
Enasidenib treatment in two individuals with D-2-hydroxyglutaric aciduria carrying a germline IDH2 mutation
Cited by 12
Semantic Scholar
Abstract 2122: The dual BRM/BRG1 (SMARCA2/4) inhibitor FHD-286 induces differentiation in preclinical models of AML
Cited by 3
Semantic Scholar
Abstract B002: Pharmacodynamics and antitumor mechanism of the BRG1/BRM (SMARCA4/2) inhibitor FHD-286 in a Phase 1 study in subjects with AML or MDS
Cited by 0
Semantic Scholar
Dysregulation of Stem-Progenitor and Differentiation Programmes through Modulation of Bivalent Chromatin Drives Leukemogenesis in Mutant IDH2 Acute Myeloid Leukaemia OA
Cited by 0
Semantic Scholar
Repressed Chromatin Drives Leukaemogenesis in Mutant IDH2 Acute Myeloid Leukaemia Via Inhibition of Granulocyte Differentiation and Cell Cycle Progression OA
Cited by 0
Semantic Scholar
Effects of azacitidine in 93 patients with IDH1/2 mutated acute myeloid leukemia/myelodysplastic syndromes: a French retrospective multicenter study
Cited by 5
Semantic Scholar
Research Topics
Acute Myeloid Leukemia Research
(41)
Epigenetics and DNA Methylation
(15)
Cancer Genomics and Diagnostics
(13)
Chronic Myeloid Leukemia Treatments
(12)
Histone Deacetylase Inhibitors Research
(12)
Affiliations
Université Paris-Sud
Délégation Paris 5
Hôpital Necker-Enfants Malades
Centre National de la Recherche Scientifique
Inserm